Correlation Between Windtree Therapeutics and Lixte Biotechnology
Can any of the company-specific risk be diversified away by investing in both Windtree Therapeutics and Lixte Biotechnology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Windtree Therapeutics and Lixte Biotechnology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Windtree Therapeutics and Lixte Biotechnology Holdings, you can compare the effects of market volatilities on Windtree Therapeutics and Lixte Biotechnology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Windtree Therapeutics with a short position of Lixte Biotechnology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Windtree Therapeutics and Lixte Biotechnology.
Diversification Opportunities for Windtree Therapeutics and Lixte Biotechnology
0.09 | Correlation Coefficient |
Significant diversification
The 3 months correlation between Windtree and Lixte is 0.09. Overlapping area represents the amount of risk that can be diversified away by holding Windtree Therapeutics and Lixte Biotechnology Holdings in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Lixte Biotechnology and Windtree Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Windtree Therapeutics are associated (or correlated) with Lixte Biotechnology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Lixte Biotechnology has no effect on the direction of Windtree Therapeutics i.e., Windtree Therapeutics and Lixte Biotechnology go up and down completely randomly.
Pair Corralation between Windtree Therapeutics and Lixte Biotechnology
Given the investment horizon of 90 days Windtree Therapeutics is expected to under-perform the Lixte Biotechnology. In addition to that, Windtree Therapeutics is 2.34 times more volatile than Lixte Biotechnology Holdings. It trades about -0.04 of its total potential returns per unit of risk. Lixte Biotechnology Holdings is currently generating about 0.0 per unit of volatility. If you would invest 331.00 in Lixte Biotechnology Holdings on September 3, 2024 and sell it today you would lose (108.00) from holding Lixte Biotechnology Holdings or give up 32.63% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Windtree Therapeutics vs. Lixte Biotechnology Holdings
Performance |
| Timeline |
| Windtree Therapeutics |
| Lixte Biotechnology |
Windtree Therapeutics and Lixte Biotechnology Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Windtree Therapeutics and Lixte Biotechnology
The main advantage of trading using opposite Windtree Therapeutics and Lixte Biotechnology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Windtree Therapeutics position performs unexpectedly, Lixte Biotechnology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Lixte Biotechnology will offset losses from the drop in Lixte Biotechnology's long position.| Windtree Therapeutics vs. DiaMedica Therapeutics | Windtree Therapeutics vs. Lyra Therapeutics | Windtree Therapeutics vs. Centessa Pharmaceuticals PLC |
| Lixte Biotechnology vs. Allarity Therapeutics | Lixte Biotechnology vs. Neurobo Pharmaceuticals | Lixte Biotechnology vs. Virax Biolabs Group | Lixte Biotechnology vs. Quoin Pharmaceuticals Ltd |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.
Other Complementary Tools
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk |